A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato

Lyme borreliosis (LB) patients who recover, as well as previously infected asymptomatic individuals, remain vulnerable to reinfection with Borrelia burgdorferi sensu lato. There is limited information available about the use of OspA vaccines in this population. In this study, a randomized double-bli...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Vaccine Immunol
Main Authors: Wressnigg, Nina, Barrett, P. Noel, Pöllabauer, Eva-Maria, O'Rourke, Maria, Portsmouth, Daniel, Schwendinger, Michael G., Crowe, Brian A., Livey, Ian, Dvorak, Thomas, Schmitt, Bernhard, Zeitlinger, Markus, Kollaritsch, Herwig, Esen, Meral, Kremsner, Peter G., Jelinek, Tomas, Aschoff, Roland, Weisser, Roland, Naudts, Ingomar F. K., Aichinger, Gerald
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2014
Assuntos:
Vaccines
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4248771/
https://ncbi.nlm.nih.gov/pubmed/25185574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00406-14
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares